1. Treatment Response Predictors of Neoadjuvant Therapy for Locally Advanced Gastric Cancer: Current Status and Future Perspectives
   Yasushi Sato et al, 2022, Biomedicines CrossRef
2. Combined Action of Anti-MUC1 Monoclonal Antibody and Pyrazole-Platinum(II) Complexes Reveals Higher Effectiveness towards Apoptotic Response in Comparison with Monotherapy in AGS Gastric Cancer Cells
   Katarzyna Supruniuk et al, 2021, Pharmaceutics CrossRef
3. Sorcin induces gastric cancer cell migration and invasion contributing to STAT3 activation
   Huan Tuo et al, 2017, Oncotarget CrossRef
4. Overexpression miR‐24‐3p repressed Bim expression to confer tamoxifen resistance in breast cancer
   Xu Han et al, 2019, Journal of Cellular Biochemistry CrossRef
5. Proteomic Signatures of Diffuse and Intestinal Subtypes of Gastric Cancer
   Smrita Singh et al, 2021, Cancers CrossRef
6. Sensitivity and Resistance to BH3 Mimetics in Cancer Therapy
   Konstantinos V. Floros et al, 2018, Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways CrossRef
7. Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma
   Jose J. G. Marin et al, 2020, Cancers CrossRef
8. Resistance to anti-microtubule drug-induced cell death is determined by regulation of BimEL expression
   Weimei Ruan et al, 2019, Oncogene CrossRef